As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
6 Analysts have issued a Profound Medical Corp forecast:
6 Analysts have issued a Profound Medical Corp forecast:
Mar '25 |
+/-
%
|
||
Revenue | 12 12 |
64%
64%
|
|
Gross Profit | 8.02 8.02 |
81%
81%
|
|
EBITDA | -36 -36 |
27%
27%
|
EBIT (Operating Income) EBIT | -36 -36 |
24%
24%
|
Net Profit | -32 -32 |
14%
14%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.
Head office | Canada |
CEO | Arun Menawat |
Employees | 142 |
Founded | 2008 |
Website | profoundmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.